Skip to content

In the BioHarmony Drug Report Database

Imlifidase

Idefirix (imlifidase) is an enzyme pharmaceutical. Imlifidase was first approved as Idefirix on 2020-08-25. It has been approved in Europe to treat immunologic desensitization and kidney transplantation.
Trade Name Idefirix
Common Name Imlifidase
Indication immunologic desensitization, kidney transplantation
Drug Class Enzymes
Imlifidase
Get full access now